Oncolytics Biotech (ONCY) Stock Chart & Stock Price History → Do This Before July 30 2024 To Claim Trump’s Gift (From Wealthpin Pro) (Ad) Free ONCY Stock Alerts $1.07 -0.01 (-0.93%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Oncolytics Biotech Stock Price Performance5 Day Performance-2.73%1 Month Performance-8.55%3 Month Performance-4.46%6 Month Performance-24.65%Year-To-Date Performance-20.74%1 Year Performance-37.79% Receive ONCY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncolytics Biotech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. ONCY Stock Chart for Sunday, June, 2, 2024 ONCY Chart by TradingView Oncolytics Biotech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$1.08$1.07-0.93%$1.09$1.0793,788 shs$81.16 million05/30/2024$1.09$1.08-0.92%$1.10$1.0781,959 shs$81.92 million05/29/2024$1.10$1.09-0.91%$1.13$1.08175,038 shs$82.68 million05/28/2024$1.09$1.10+0.92%$1.14$1.09184,231 shs$83.44 million05/27/2024$1.09$1.09$1.11$1.06250,800 shs$82.68 million05/24/2024$1.06$1.09+2.83%$1.11$1.06238,342 shs$82.68 million Get the Latest News and Ratings for ONCY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncolytics Biotech and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$1.10$1.06-3.64%$1.11$1.05202,191 shs$80.40 million05/22/2024$1.11$1.10-0.90%$1.11$1.08140,185 shs$83.44 million05/21/2024$1.12$1.11-0.89%$1.13$1.09169,585 shs$84.19 million05/20/2024$1.11$1.12+0.90%$1.14$1.10272,360 shs$84.95 million05/17/2024$1.13$1.11-1.77%$1.15$1.10282,704 shs$84.19 million05/16/2024$1.16$1.13-2.59%$1.17$1.13266,873 shs$85.71 million05/15/2024$1.18$1.16-1.69%$1.23$1.14339,577 shs$87.99 million05/14/2024$1.17$1.18+0.85%$1.20$1.16206,990 shs$89.50 million05/13/2024$1.17$1.17$1.21$1.15159,645 shs$88.74 million05/10/2024$1.24$1.17-5.65%$1.25$1.14327,837 shs$88.75 million05/09/2024$1.18$1.24+5.08%$1.28$1.17715,894 shs$89.51 million05/08/2024$1.19$1.18-0.84%$1.19$1.1592,046 shs$89.00 million05/07/2024$1.18$1.19+0.85%$1.20$1.14134,414 shs$89.75 million05/06/2024$1.17$1.18+0.85%$1.19$1.16102,797 shs$89.00 million05/03/2024$1.17$1.16-0.85%$1.19$1.1697,754 shs$87.49 million05/02/2024$1.12$1.17+4.46%$1.17$1.13154,315 shs$88.24 million05/01/2024$1.11$1.12+0.90%$1.15$1.08227,382 shs$84.47 million04/30/2024$1.09$1.11+1.83%$1.11$1.0894,631 shs$83.72 million04/29/2024$1.09$1.09$1.13$1.09123,544 shs$82.21 million04/26/2024$1.08$1.09+0.93%$1.10$1.06219,102 shs$82.21 million04/25/2024$1.06$1.08+1.89%$1.12$1.03302,083 shs$81.45 million04/24/2024$1.06$1.06$1.07$1.0361,862 shs$79.95 million04/23/2024$1.04$1.06+1.92%$1.07$1.0455,895 shs$79.95 million04/22/2024$1.06$1.04-1.89%$1.08$1.04109,363 shs$78.44 million04/19/2024$1.03$1.06+2.91%$1.06$1.03107,021 shs$79.95 million04/18/2024$1.04$1.03-0.96%$1.06$1.02158,995 shs$77.68 million04/17/2024$1.08$1.04-3.70%$1.08$1.02178,056 shs$78.44 million04/16/2024$1.06$1.08+1.89%$1.08$1.01260,227 shs$81.45 million04/15/2024$1.14$1.06-7.02%$1.16$1.03331,112 shs$79.95 million04/12/2024$1.15$1.14-0.87%$1.15$1.09226,362 shs$85.98 million04/11/2024$1.13$1.15+1.77%$1.16$1.08255,116 shs$86.73 million04/10/2024$1.16$1.13-2.59%$1.16$1.06425,573 shs$85.23 million04/09/2024$1.16$1.16$1.20$1.13142,248 shs$87.49 million04/08/2024$1.15$1.16+0.87%$1.20$1.09254,073 shs$87.49 million[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now.04/05/2024$1.15$1.15$1.25$1.15830,572 shs$86.73 million04/04/2024$1.10$1.15+4.55%$1.29$1.12850,680 shs$86.73 million04/03/2024$1.07$1.10+2.80%$1.10$1.04234,592 shs$82.96 million04/02/2024$1.06$1.07+0.94%$1.07$1.03122,764 shs$80.70 million04/01/2024$1.06$1.06$1.07$1.03133,819 shs$79.95 million03/29/2024$1.06$1.06$1.06$1.01294,224 shs$79.95 million03/28/2024$1.03$1.06+2.91%$1.06$1.01294,181 shs$79.95 million03/27/2024$1.01$1.03+1.98%$1.03$1.01124,196 shs$77.68 million03/26/2024$1.03$1.01-1.94%$1.03$1.00105,159 shs$76.17 million03/25/2024$1.00$1.03+3.00%$1.03$1.01182,814 shs$77.68 million03/22/2024$1.03$1.00-2.91%$1.02$1.00123,935 shs$75.42 million03/21/2024$1.01$1.03+1.98%$1.03$1.01106,736 shs$77.68 million03/20/2024$1.03$1.01-1.94%$1.03$1.0090,713 shs$76.17 million03/19/2024$1.04$1.03-0.96%$1.03$1.00132,767 shs$77.68 million03/18/2024$0.99$1.04+5.17%$1.05$0.97324,751 shs$78.44 million03/15/2024$1.02$0.99-3.05%$1.02$0.97398,409 shs$74.58 million03/14/2024$1.04$1.02-1.92%$1.04$1.00224,160 shs$76.93 million03/13/2024$1.06$1.04-1.89%$1.06$1.02164,204 shs$78.44 million03/12/2024$1.06$1.06$1.07$1.02148,200 shs$79.92 million03/11/2024$1.05$1.06+0.95%$1.08$1.01186,451 shs$79.95 million03/08/2024$1.04$1.05+0.96%$1.12$1.01424,985 shs$79.17 million03/07/2024$1.04$1.04$1.08$1.00415,559 shs$78.41 million03/06/2024$1.03$1.04+0.97%$1.04$0.99255,848 shs$78.42 million03/05/2024$0.92$1.03+11.96%$1.04$0.98427,682 shs$77.66 million03/04/2024$1.12$0.92-17.86%$1.16$0.891.75 million shs$69.37 million03/01/2024$1.14$1.12-1.75%$1.18$1.07409,514 shs$84.45 million Related Companies: Enlivex Therapeutics Stock Chart Orgenesis Stock Chart Alto Neuroscience Stock Chart Silverback Therapeutics Stock Chart Nkarta Stock Chart UroGen Pharma Stock Chart Q32 Bio Stock Chart Nanobiotix Stock Chart Atea Pharmaceuticals Stock Chart Kamada Stock Chart Receive ONCY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncolytics Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ONCY) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward PressNext President (Not Trump. Not Biden.)The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncolytics Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.